What is hsCRP (high-sensitivity C-Reactive Protein)?

hsCRP is a blood test that measures low levels of inflammation in your body, serving as a powerful predictor of cardiovascular disease risk even when cholesterol levels appear normal.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

High-sensitivity C-reactive protein (hsCRP) is one of the most important biomarkers for assessing your cardiovascular health and overall inflammation status. Unlike traditional cholesterol tests that only tell part of the story, hsCRP provides crucial insights into the inflammatory processes that drive heart disease, stroke, and other chronic conditions. This advanced blood test can detect even subtle levels of systemic inflammation, making it an invaluable tool for early disease prevention and health optimization.

Understanding C-Reactive Protein and Its High-Sensitivity Version

C-reactive protein (CRP) is a substance produced by your liver in response to inflammation anywhere in your body. When tissues are injured, infected, or under stress, your immune system triggers the release of inflammatory signals that prompt CRP production. Traditional CRP tests were designed to detect high levels of inflammation associated with acute infections or severe inflammatory conditions.

The high-sensitivity version (hsCRP) represents a significant advancement in testing technology. While standard CRP tests can only detect levels above 3-5 mg/L, hsCRP can accurately measure concentrations as low as 0.1 mg/L. This enhanced sensitivity allows healthcare providers to identify chronic, low-grade inflammation that may be silently damaging your cardiovascular system years before symptoms appear.

hsCRP Risk Categories for Cardiovascular Disease

hsCRP Level (mg/L)Risk CategoryCardiovascular RiskRecommended Action
Less than 1.0<1.0 mg/LLow RiskLower risk of heart diseaseMaintain healthy lifestyle
1.0-3.01.0-3.0 mg/LModerate RiskAverage risk of heart diseaseLifestyle modifications, monitor regularly
Greater than 3.0>3.0 mg/LHigh RiskHigher risk of heart diseaseAggressive risk reduction, medical evaluation
Greater than 10.0>10.0 mg/LVery HighMay indicate acute inflammationRule out infection or inflammatory condition

Risk categories are based on American Heart Association and CDC guidelines for cardiovascular disease prediction.

The Science Behind Inflammation and Heart Disease

Research has revolutionized our understanding of heart disease beyond the traditional focus on cholesterol alone. Scientists now recognize that inflammation plays a central role in atherosclerosis—the process where plaque builds up in arteries. When your artery walls become inflamed, they're more likely to develop fatty deposits, and existing plaques become unstable and prone to rupture, potentially causing heart attacks or strokes.

The landmark JUPITER trial, published in the New England Journal of Medicine, demonstrated that people with normal cholesterol levels but elevated hsCRP had significantly higher cardiovascular risk. This groundbreaking study led to hsCRP being recognized as an independent risk factor for heart disease, separate from traditional lipid markers.

hsCRP Reference Ranges and Risk Categories

Understanding your hsCRP levels is crucial for assessing cardiovascular risk. The American Heart Association and Centers for Disease Control and Prevention have established specific risk categories based on extensive research involving hundreds of thousands of participants.

Interpreting Your Results

Low risk (less than 1.0 mg/L) indicates minimal systemic inflammation and lower cardiovascular risk. However, this doesn't mean you should ignore other risk factors like blood pressure, cholesterol, or lifestyle habits. Moderate risk (1.0-3.0 mg/L) suggests some degree of chronic inflammation that warrants attention and lifestyle modifications.

High risk (greater than 3.0 mg/L) indicates significant inflammation and substantially increased cardiovascular risk. If your hsCRP falls in this range, it's important to work with your healthcare provider to identify underlying causes and implement aggressive risk reduction strategies. Regular monitoring becomes essential to track your progress and adjust interventions as needed.

Common Causes of Elevated hsCRP Levels

Multiple factors can contribute to elevated hsCRP levels, ranging from lifestyle choices to underlying medical conditions. Understanding these causes helps you take targeted action to reduce inflammation and improve your cardiovascular health.

Lifestyle and Environmental Factors

  • Poor diet high in processed foods, refined sugars, and trans fats
  • Sedentary lifestyle and lack of regular physical activity
  • Chronic stress and inadequate stress management
  • Insufficient sleep or poor sleep quality
  • Smoking and excessive alcohol consumption
  • Obesity, particularly abdominal fat accumulation
  • Environmental toxin exposure

Medical Conditions and Health Issues

Several health conditions can drive chronic inflammation and elevate hsCRP levels. Autoimmune disorders like rheumatoid arthritis, lupus, and inflammatory bowel disease create ongoing inflammatory responses. Metabolic conditions including diabetes, insulin resistance, and metabolic syndrome also contribute to systemic inflammation.

Infections, both acute and chronic, can significantly impact hsCRP levels. Even low-grade infections like periodontal disease or chronic sinusitis may contribute to elevated readings. Additionally, certain medications, hormonal changes, and genetic factors can influence your inflammatory status.

The Clinical Significance of hsCRP Testing

hsCRP testing provides valuable clinical information that extends beyond traditional cardiovascular risk assessment. Healthcare providers use hsCRP results to refine risk stratification, especially in patients with intermediate risk based on conventional factors like age, cholesterol, and blood pressure.

The test is particularly valuable for individuals who appear healthy based on standard metrics but may harbor hidden cardiovascular risk. Studies show that hsCRP can identify up to 20% of people at high cardiovascular risk who would be missed by traditional screening methods alone.

Beyond Heart Disease: Other Health Implications

While cardiovascular risk assessment remains the primary clinical application, elevated hsCRP levels have been associated with increased risk of diabetes, certain cancers, and cognitive decline. Chronic inflammation appears to be a common pathway underlying many age-related diseases, making hsCRP a valuable marker for overall health and longevity.

Research suggests that people with consistently low hsCRP levels tend to age more successfully, maintaining better physical and cognitive function as they get older. This makes hsCRP monitoring an important component of preventive healthcare and health optimization strategies.

Strategies to Lower hsCRP Levels Naturally

The good news is that hsCRP levels are highly responsive to lifestyle interventions. Unlike genetic factors you can't change, inflammation is largely modifiable through targeted strategies that address its root causes.

Dietary Approaches

An anti-inflammatory diet forms the foundation of hsCRP reduction. Focus on whole, unprocessed foods rich in omega-3 fatty acids, antioxidants, and phytonutrients. The Mediterranean diet pattern has been extensively studied and shown to significantly reduce inflammatory markers.

  • Fatty fish like salmon, mackerel, and sardines (2-3 times per week)
  • Colorful vegetables and fruits, especially berries and leafy greens
  • Nuts, seeds, and olive oil as primary fat sources
  • Whole grains instead of refined carbohydrates
  • Herbs and spices with anti-inflammatory properties (turmeric, ginger, garlic)

Exercise and Physical Activity

Regular physical activity is one of the most powerful interventions for reducing systemic inflammation. Both aerobic exercise and resistance training have been shown to lower hsCRP levels, with the greatest benefits seen in people who transition from sedentary to active lifestyles.

Aim for at least 150 minutes of moderate-intensity exercise per week, or 75 minutes of vigorous activity. Include strength training exercises at least twice weekly. Even modest increases in physical activity can produce meaningful reductions in inflammatory markers within weeks.

When and How Often to Test hsCRP

The timing and frequency of hsCRP testing depend on your individual risk profile and health goals. For cardiovascular risk assessment, the American Heart Association recommends considering hsCRP testing in adults at intermediate risk based on traditional risk factors.

If you're implementing lifestyle changes to reduce inflammation, testing every 3-6 months allows you to monitor progress and adjust strategies as needed. This frequency provides enough time for interventions to take effect while maintaining momentum in your health optimization journey.

Factors That Can Affect Test Results

Several factors can temporarily elevate hsCRP levels and should be considered when interpreting results. Acute infections, recent injuries, or inflammatory flare-ups can cause significant spikes that don't reflect your baseline inflammatory status.

For the most accurate assessment, avoid testing during illness or within two weeks of any acute inflammatory event. Some medications, including statins and certain supplements, can influence hsCRP levels, so discuss these with your healthcare provider when reviewing results.

Taking Control of Your Inflammatory Health

hsCRP testing represents a paradigm shift in preventive healthcare, moving beyond traditional risk factors to identify hidden inflammation that could be silently damaging your health. By understanding your hsCRP levels and the factors that influence them, you gain powerful insights into your cardiovascular risk and overall health status.

The beauty of hsCRP as a biomarker lies in its responsiveness to positive lifestyle changes. Unlike genetic factors you can't modify, inflammation levels can be significantly improved through targeted interventions. Whether your goal is preventing heart disease, optimizing longevity, or simply feeling your best, monitoring and managing your inflammatory status through hsCRP testing provides a clear pathway to better health.

Remember that hsCRP is just one piece of your health puzzle. The most comprehensive approach combines hsCRP monitoring with other key biomarkers, lifestyle assessments, and regular healthcare provider consultations to create a complete picture of your health and guide personalized optimization strategies.

References

  1. Ridker, P. M., Danielson, E., Fonseca, F. A., et al. (2008). Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine, 359(21), 2195-2207.[PubMed][DOI]
  2. Pearson, T. A., Mensah, G. A., Alexander, R. W., et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation, 107(3), 499-511.[PubMed][DOI]
  3. Koenig, W., Sund, M., Fröhlich, M., et al. (1999). C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation, 99(2), 237-242.[PubMed][DOI]
  4. Libby, P., Ridker, P. M., & Hansson, G. K. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature, 473(7347), 317-325.[PubMed][DOI]
  5. Emerging Risk Factors Collaboration. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 375(9709), 132-140.[PubMed][DOI]
  6. Kasapis, C., & Thompson, P. D. (2005). The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. Journal of the American College of Cardiology, 45(10), 1563-1569.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my hsCRP at home?

You can test your hsCRP at home with SiPhox Health's Core Health Program or Heart & Metabolic Program. Both programs include hsCRP testing along with other key cardiovascular and inflammatory markers, providing lab-quality results from the comfort of your home.

What is the normal range for hsCRP?

hsCRP levels are categorized as low risk (less than 1.0 mg/L), moderate risk (1.0-3.0 mg/L), and high risk (greater than 3.0 mg/L) for cardiovascular disease. The lower your hsCRP, the better for your long-term health.

How often should I test my hsCRP levels?

For cardiovascular risk assessment, annual testing may be sufficient if levels are stable and low. However, if you're implementing lifestyle changes to reduce inflammation or have elevated levels, testing every 3-6 months allows you to monitor progress effectively.

Can diet and exercise really lower hsCRP levels?

Yes, lifestyle interventions are highly effective at reducing hsCRP levels. An anti-inflammatory diet rich in omega-3 fatty acids and antioxidants, combined with regular exercise, can significantly lower inflammatory markers within weeks to months.

What's the difference between regular CRP and hsCRP?

High-sensitivity CRP (hsCRP) can detect much lower levels of inflammation than standard CRP tests. While regular CRP is used to diagnose acute infections or severe inflammation, hsCRP can identify chronic, low-grade inflammation associated with cardiovascular disease risk.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details